| 18:15 |
Business Meeting |
| 18:30 |
The Great Debates in MR in Drug
Research |
| 18:30 |
MRI for Body Composition Assessment Has Little Value for
Drug Development Studies
Moderator: Bradley Wyman, Ph.D. |
| |
|
Pro: Paul Hockings, Ph.D., TBD |
Con: Jeff
Evelhoch, Ph.D., TBD |
|
| 19:05 |
MRI is a Superior Modality for Assessing Rheumatoid
Arthritis or Osteoarthritis Disease Progression in Drug
Related Studies
Moderator: TBD |
| |
|
Pro: Joshua Farber, M.D., Bradley Wyman, Ph.D. |
Con: Derek
Hill, Ph.D., John Waterton, Ph.D. |
|
| 19:40 |
The Use of MRI for Oncology Drug Trials Should be Severely
Limited
Moderator: John Hazle, Ph.D. |
| |
|
Pro: Edward Ashton, Ph.D., TBD |
Con:
Yanping Luo, Ph.D., TBD |
|
| 20:15 |
Adjourn |
| |
|
|
